Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data.

Authors: Boyle B. et al.

Source: Arch Dis Child Fetal Neonatal Ed. 2017 Jun 30. pii: fetalneonatal-2016-311845. doi: 10.1136/archdischild-2016-311845.

Objective: To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for Europe by comparing infant mortality data collected by EUROCAT registries with the WHO Mortality Database, and by assessing the significance of stillbirths and terminations of pregnancy for fetal anomaly (TOPFA) in the interpretation of infant mortality statistics.

Read Abstract

Select your region and press submit to request this article from your local library


Share this article
Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedIn